ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

September 09, 2010 16:45 ET

ProMetic to Present at Rodman & Renshaw's Twelfth Annual Healthcare Conference

MONTREAL, QUEBEC--(Marketwire - Sept. 9, 2010) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announced that Mr. Pierre Laurin, President and Chief Executive Officer, will present at Rodman & Renshaw's Twelfth Annual Healthcare Conference. ProMetic's presentation is scheduled for 12:05 (EDT) on Monday, September 13, 2010. The conference is being held from September 12 - 15, 2010, at the New York Palace Hotel in New York. Details regarding the conference can be obtained at

Individuals may listen to a live web cast of the presentation by logging on to ProMetic's web site a few minutes prior to start time to download any necessary software.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ( is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and business development activities in the U.S., Europe, Asia and in the Middle-East.

Contact Information

  • ProMetic Life Sciences Inc.
    Pierre Laurin
    President and CEO
    ProMetic Life Sciences Inc.
    Anne Leduc
    Manager, Investor Relations & Communications